StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CureVac N.V.
Frankfurt Stock Exchange:5CV.F
Sector
Location
Market Cap
USD 1.23 B
Share Price
USD 5.45
Avg Daily Volume
28,767
Change (1 day)
0.39%
Change (1 year)
79.99%
Change (YTD)
77.52%
CureVac N.V. Operating Cash Flow for the year ending December 31, 2024: USD 105.47 M
CureVac N.V. Operating Cash Flow is USD 105.47 M for the year ending December 31, 2024, a -135.67% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
CureVac N.V. Operating Cash Flow for the year ending December 31, 2023 was USD -295.68 M, a -3.43% change year over year.
-
CureVac N.V. Operating Cash Flow for the year ending December 31, 2022 was USD -306.19 M, a -63.31% change year over year.
-
CureVac N.V. Operating Cash Flow for the year ending December 31, 2021 was USD -834.56 M, a -230.78% change year over year.
-
CureVac N.V. Operating Cash Flow for the year ending December 31, 2020 was USD 638.15 M, a -753.89% change year over year.
Competitors
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Moderna, Inc.
USD 32.79
MRNA
+0.25
0.77%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.41
603392.SS
+0.06
0.71%
Swedish Orphan Biovitrum AB (publ)
USD 29.69
SOBI.ST
-0.12
-0.40%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.78
300122.SZ
+0.02
0.67%
Ionis Pharmaceuticals, Inc.
USD 42.83
IONS
+1.49
3.60%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.16
1877.HK
+0.06
1.85%
Vaxcyte, Inc.
USD 35.78
PCVX
+2.32
6.93%
Rhythm Pharmaceuticals, Inc.
USD 89.00
RYTM
+23.86
36.63%
Hualan Biological Engineering Inc.
USD 2.20
002007.SZ
-0.01
-0.53%
Apogee Therapeutics, Inc.
USD 37.02
APGE
+0.61
1.68%
Apellis Pharmaceuticals, Inc.
USD 19.21
APLS
+1.32
7.38%
NewAmsterdam Pharma Company N.V.
USD 21.64
NAMS
+1.62
8.09%
Ligand Pharmaceuticals Incorporated
USD 122.40
LGND
+7.28
6.32%
Bavarian Nordic A/S
USD 27.52
BAVA.CO
+0.50
1.85%
Adaptive Biotechnologies Corporation
USD 11.93
ADPT
+0.19
1.62%
ARS Pharmaceuticals, Inc.
USD 17.90
SPRY
+0.95
5.61%
Immunocore Holdings plc
USD 34.58
IMCR
+1.30
3.91%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Novo Nordisk A/S
USD 69.43
NOVO-B.CO
-1.17
-1.65%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Moderna, Inc.
USD 32.79
MRNA
+0.25
0.77%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.41
603392.SS
+0.06
0.71%
Swedish Orphan Biovitrum AB (publ)
USD 29.69
SOBI.ST
-0.12
-0.40%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.78
300122.SZ
+0.02
0.67%
Ionis Pharmaceuticals, Inc.
USD 42.83
IONS
+1.49
3.60%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.16
1877.HK
+0.06
1.85%
Vaxcyte, Inc.
USD 35.78
PCVX
+2.32
6.93%
Rhythm Pharmaceuticals, Inc.
USD 89.00
RYTM
+23.86
36.63%
Hualan Biological Engineering Inc.
USD 2.20
002007.SZ
-0.01
-0.53%
Apogee Therapeutics, Inc.
USD 37.02
APGE
+0.61
1.68%
Apellis Pharmaceuticals, Inc.
USD 19.21
APLS
+1.32
7.38%
NewAmsterdam Pharma Company N.V.
USD 21.64
NAMS
+1.62
8.09%
Ligand Pharmaceuticals Incorporated
USD 122.40
LGND
+7.28
6.32%
Bavarian Nordic A/S
USD 27.52
BAVA.CO
+0.50
1.85%
Adaptive Biotechnologies Corporation
USD 11.93
ADPT
+0.19
1.62%
ARS Pharmaceuticals, Inc.
USD 17.90
SPRY
+0.95
5.61%
Immunocore Holdings plc
USD 34.58
IMCR
+1.30
3.91%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Novo Nordisk A/S
USD 69.43
NOVO-B.CO
-1.17
-1.65%